arrow-next arrow-prev

Oliver Keown

Senior Associate

Oliver is Senior Associate of Investing. Based in Menlo Park, CA, he joined in 2016. 

He supports healthcare investment diligence and deal flow across digital health, HCIT, precision medicine and medical device domains, while engaging in policy analysis and strategic international development opportunities at the intersections of venture capital and health policy.  

Previously, Oliver was Clinical Advisor and Policy Fellow at the Institute of Global Health Innovation, Imperial College London, and Clinical Advisor to the Institute’s Director, Professor the Lord Darzi of Denham. In this role, he led and advised a range of international and UK-based healthcare projects across technology, policy, parliamentary, commercial, and academic fields. His responsibilities included considerable international work in Qatar and Myanmar, and liaising with the UK House of Lords to support policy initiatives for public and population health.  

Starting his career as a junior doctor in the UK National Health Service, Oliver transitioned out of clinical practice to pursue his passion for digital health, technology and policy. While attending University and beyond, he sat as a clinical representative and committee member for the British Pharmacological Society.  

Oliver holds an MBChB Medicine degree (MD equivalent) and a Bachelors of Medical Science in Pharmacology from the University of Edinburgh, Scotland.  

He has published academic papers and editorials in The Lancet, British Medical Journal, Health Affairs and with The King’s Fund on topics spanning population health, precision medicine, antimicrobial resistance, behavioral design for smoking cessation, the economic impact of Brexit, and the diffusion of healthcare innovation across global markets. 

Oliver’s favorite pastime is anything to do with cooking or eating, especially hosting dinner parties.